These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12536676)

  • 61. [Hepatocyte transformation and tumor development induced by hepatitis C virus NS3 N-terminal protein].
    He QQ; Cheng RX; Sun Y; Feng DY; Zheng H
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):255-9. PubMed ID: 12882694
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inducible nitric oxide synthase expression in chronic viral hepatitis and its relation with histological severity of disease.
    Kandemir O; Polat A; Kaya A
    J Viral Hepat; 2002 Nov; 9(6):419-23. PubMed ID: 12431203
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intestinal expressions of eNOSmRNA and iNOSmRNA in rats with acute liver failure.
    Qin JM; Zhang YD
    World J Gastroenterol; 2001 Oct; 7(5):652-6. PubMed ID: 11819848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of HCV infection on expression of several cancer-associated gene products in HCC.
    Yang JM; Wang RQ; Bu BG; Zhou ZC; Fang DC; Luo YH
    World J Gastroenterol; 1999 Feb; 5(1):25-27. PubMed ID: 11819378
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis C virus infection and myositis: a virus localization study.
    Di Muzio A; Bonetti B; Capasso M; Panzeri L; Pizzigallo E; Rizzuto N; Uncini A
    Neuromuscul Disord; 2003 Jan; 13(1):68-71. PubMed ID: 12467735
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Studies on tissue expression of HCV proteins (NS3 and C) in chronic hepatitis C using the ImmunoMax technique.
    Kasprzak A; Biczysko W; Adamek A; Wysocki J; Zabel M; Jurczyszyn D; Chmielewski M; Surdyk-Zasada J
    Scand J Gastroenterol; 2004 Apr; 39(4):387-8. PubMed ID: 15125473
    [No Abstract]   [Full Text] [Related]  

  • 67. [The effect of HCV NS3 protein on expression of p53 gene protein in hepatocarcinogenesis].
    Feng D; Zheng H; Yan Y
    Zhonghua Yi Xue Za Zhi; 1998 Apr; 78(4):278-80. PubMed ID: 10923485
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
    Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the inhibitory effect of antisense oligodeoxynucleotides on the growth of hepatitis C-associated hepatocellular carcinoma cells in vitro.
    Amin MA; Awadein MR; Gabr H
    Chin J Dig Dis; 2005; 6(3):142-8. PubMed ID: 16045605
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk of hepatocellular carcinoma and secondary structure of hepatitis C virus (HCV) NS3 protein amino-terminus, in patients infected with HCV subtype 1b.
    Nishise Y; Saito T; Sugahara K; Ito JI; Saito K; Togashi H; Nagano-Fujii M; Hotta H; Kawata S
    J Infect Dis; 2007 Oct; 196(7):1006-9. PubMed ID: 17763321
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Viral hepatitis and liver cancer: the case of hepatitis C.
    Levrero M
    Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
    Koike K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of hepatitis C virus NS3 protein on expression of iNOS mRNA in hepatocarcinogenesis].
    Feng DY; Cheng RX; Zheng H
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):192-4. PubMed ID: 12536676
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.